Literature DB >> 33683478

Prefrontal dopamine D1 receptor manipulation influences anxiety behavior and induces neuroinflammation within the hippocampus.

Dominik K E Beyer1, Annika Mattukat1, Nadja Freund2.   

Abstract

BACKGROUND: Prefrontal dopamine D1 receptor (D1R) mediates behavior related to anxiety, reward and memory, and is involved in inflammatory processes, all of which are affected in bipolar disorder. Interleukin-6 (IL-6), a pro-inflammatory cytokine, is increased in patients with bipolar disorder in plasma samples, imaging studies and postmortem tissue and is an indicator for an inflammatory state. We could previously show that lentiviral overexpression of D1R in the medial prefrontal cortex (mPFC) of male adult rats and its termination induces bipolar disorder-like behavior. The purpose of this study was to investigate anxiety and the role of the immune system, specifically IL-6 positive neurons in this animal model. Due to its high density of inflammatory mediator receptors and therewith sensibility to immune activation, the hippocampus was investigated.
METHODS: Expression of the gene for D1R in glutamatergic neurons within the mPFC of male, adult rats was manipulated through an inducible lentiviral vector. Animals over-expressing the gene (mania-like state), after termination of the expression (depressive-like) and their respective control groups were investigated. Anxiety behavior was studied in the elevated plus maze and marble burying test. Furthermore, IL-6-positive cells were counted within several subregions of the hippocampus.
RESULTS: D1R manipulation in the mPFC had only mild effects on anxiety behavior in the elevated plus maze. However, subjects after termination buried more marbles compared to D1R over-expressing animals and their respective control animals indicating elevated anxiety behavior. In addition, animals in the depressive-like state showed higher numbers of IL-6 positive cells reflecting an elevated pro-inflammatory state in the hippocampus, in the CA3 and dentate gyrus. Consistently, inflammatory state in the whole hippocampus and anxiety behavior correlated positively, indicating a connection between anxiety and inflammatory state of the hippocampus.
CONCLUSIONS: Behavioral and neurobiological findings support the association of manipulation of the D1R in the mPFC on anxiety and inflammation in the hippocampus. In addition, by confirming changes in the inflammatory state, the proposed animal model for bipolar disorder has been further validated.

Entities:  

Keywords:  Anxiety; Bipolar disorder; Interleukin-6; Lentivirus; Prefrontal cortex; Rat

Year:  2021        PMID: 33683478     DOI: 10.1186/s40345-020-00212-2

Source DB:  PubMed          Journal:  Int J Bipolar Disord        ISSN: 2194-7511


  54 in total

1.  Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.

Authors:  Lucile Capuron; Giuseppe Pagnoni; Daniel F Drake; Bobbi J Woolwine; James R Spivey; Ronald J Crowe; John R Votaw; Mark M Goodman; Andrew H Miller
Journal:  Arch Gen Psychiatry       Date:  2012-10

2.  Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder.

Authors:  Francesco Benedetti; Sara Poletti; Thomas A Hoogenboezem; Clara Locatelli; Harm de Wit; Annemarie J M Wijkhuijs; Cristina Colombo; Hemmo A Drexhage
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

3.  Therapeutic potential of interleukin-6 antagonism in bipolar disorder.

Authors:  E Brietzke; M Scheinberg; B Lafer
Journal:  Med Hypotheses       Date:  2010-09-15       Impact factor: 1.538

4.  Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.

Authors:  Naomi I Eisenberger; Elliot T Berkman; Tristen K Inagaki; Lian T Rameson; Nehjla M Mashal; Michael R Irwin
Journal:  Biol Psychiatry       Date:  2010-08-16       Impact factor: 13.382

5.  Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.

Authors:  Iain L Campbell; Maria Erta; Sue Ling Lim; Ricardo Frausto; Ulrike May; Stefan Rose-John; Jürgen Scheller; Juan Hidalgo
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

6.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

Authors:  I L Campbell; C R Abraham; E Masliah; P Kemper; J D Inglis; M B Oldstone; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder.

Authors:  Elisa Brietzke; Márcia Kauer-Sant'Anna; Antônio Lúcio Teixeira; Flávio Kapczinski
Journal:  Brain Behav Immun       Date:  2009-05-04       Impact factor: 7.217

8.  Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.

Authors:  Elisa Brietzke; Laura Stertz; Brisa Simões Fernandes; Marcia Kauer-Sant'anna; Marcello Mascarenhas; Andréia Escosteguy Vargas; José Artur Chies; Flávio Kapczinski
Journal:  J Affect Disord       Date:  2009-02-28       Impact factor: 4.839

Review 9.  Imaging the Role of Inflammation in Mood and Anxiety-related Disorders.

Authors:  Jennifer C Felger
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 10.  So depression is an inflammatory disease, but where does the inflammation come from?

Authors:  Michael Berk; Lana J Williams; Felice N Jacka; Adrienne O'Neil; Julie A Pasco; Steven Moylan; Nicholas B Allen; Amanda L Stuart; Amie C Hayley; Michelle L Byrne; Michael Maes
Journal:  BMC Med       Date:  2013-09-12       Impact factor: 8.775

View more
  2 in total

1.  Innate immune stimulation by monophosphoryl lipid A prevents chronic social defeat stress-induced anxiety-like behaviors in mice.

Authors:  Fu Li; Haitao Xiang; Yue Gu; Ting Ye; Xu Lu; Chao Huang
Journal:  J Neuroinflammation       Date:  2022-01-07       Impact factor: 8.322

Review 2.  Unraveling the mystery of white matter in depression: A translational perspective on recent advances.

Authors:  Mate Abraham; Annakarina Mundorf; Katja Brodmann; Nadja Freund
Journal:  Brain Behav       Date:  2022-06-01       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.